Thomas Higgins
Director of Finance/CFO at NEUROMETRIX, INC.
Net worth: 35 904 $ as of 2024-03-30
Profile
Thomas T.
Higgins currently works at NeuroMetrix, Inc., as Chief Financial Officer, Treasurer & Senior VP and Panacos Pharmaceuticals, Inc., as Chief Financial Officer.
Mr. Higgins also formerly worked at Cabot Corp., as Vice President & General Manager-Asia Pacific, V.I.
Technologies, Inc., as Chief Financial Officer & Executive VP-Operations from 1998 to 2005, Caliper Life Sciences, Inc., as Chief Financial Officer & Executive Vice President from 2005 to 2008, and Distrigas of Massachusetts Corp., as President.
Mr. Higgins received his undergraduate degree from Boston University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NEUROMETRIX, INC.
0.43% | 2024-03-31 | 8,448 ( 0.43% ) | 35 904 $ | 2024-03-30 |
Thomas Higgins active positions
| Companies | Position | Start |
|---|---|---|
| NEUROMETRIX, INC. | Director of Finance/CFO | 2009-09-09 |
| PANACOS PHARMACEUTICALS, INC. | Director of Finance/CFO | - |
Former positions of Thomas Higgins
| Companies | Position | End |
|---|---|---|
Caliper Life Sciences, Inc.
 Caliper Life Sciences, Inc. SemiconductorsElectronic Technology Caliper Life Sciences, Inc. develops, manufactures, and sells labchip systems. It offers microfluids, lab automation, liquid handling, optical imaging technologies, and discovery and development outsourcing solutions. The company was founded by Michael R. Knapp on July 26, 1995 and is headquartered in Hopkinton, MA. | Director of Finance/CFO | 2008-02-29 |
V.I. Technologies, Inc.
 V.I. Technologies, Inc. BiotechnologyHealth Technology Vitex is a Delaware Corporation incorporated in 1995. Vitex’s scientific and clinical programs originated in anti-infective technologies designed to prevent the spread of infectious disease by blood transfusions. In March of 2005, Vitex merged with Panacos Pharmaceuticals, a private company developing HIV therapeutics with novel mechanisms of action. The merger with Panacos immediately expanded the Vitex pipeline into novel, high value therapeutics. The Panacos team that joined Vitex is recognized for fundamental contributions to HIV biology and drug development | Director of Finance/CFO | 2005-08-14 |
| Distrigas of Massachusetts Corp. | President | - |
| CABOT CORPORATION | Corporate Officer/Principal | - |
Training of Thomas Higgins
| Boston University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| CABOT CORPORATION | Process Industries |
| NEUROMETRIX, INC. | Health Technology |
| PANACOS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
V.I. Technologies, Inc.
V.I. Technologies, Inc. BiotechnologyHealth Technology Vitex is a Delaware Corporation incorporated in 1995. Vitex’s scientific and clinical programs originated in anti-infective technologies designed to prevent the spread of infectious disease by blood transfusions. In March of 2005, Vitex merged with Panacos Pharmaceuticals, a private company developing HIV therapeutics with novel mechanisms of action. The merger with Panacos immediately expanded the Vitex pipeline into novel, high value therapeutics. The Panacos team that joined Vitex is recognized for fundamental contributions to HIV biology and drug development | Health Technology |
Caliper Life Sciences, Inc.
Caliper Life Sciences, Inc. SemiconductorsElectronic Technology Caliper Life Sciences, Inc. develops, manufactures, and sells labchip systems. It offers microfluids, lab automation, liquid handling, optical imaging technologies, and discovery and development outsourcing solutions. The company was founded by Michael R. Knapp on July 26, 1995 and is headquartered in Hopkinton, MA. | Electronic Technology |
| Distrigas of Massachusetts Corp. |
- Stock Market
- Insiders
- Thomas Higgins
